Bodicoat, Danielle H., Schoemaker, Minouk J., Jones, Michael E., McFadden, Emily, Griffin, James, Ashworth, Alan and Swerdlow, Anthony J. (2014) Timing of pubertal stages and breast cancer risk : the Breakthrough Generations Study. Breast Cancer Research, 16 (1). pp. 1-8. R18. doi:10.1186/bcr3613 ISSN 1465-542X.

Preview

PDF WRAP_art%3A10.1186%2Fbcr3613.pdf - Published Version - Requires a PDF viewer. Available under License Creative Commons Attribution 2.0.. Download (327Kb) | Preview

Request Changes to record.

Abstract

Introduction:
Breast development and hormonal changes at puberty might affect breast cancer risk, but epidemiological analyses have focussed largely on age at menarche and not at other pubertal stages. Methods: We investigated associations between the timing of pubertal stages and breast cancer risk using data from a cohort study of 104,931 women (Breakthrough Generations Study, UK, 2003–2013). Pubertal variables were reported retrospectively at baseline. Breast cancer risk was analysed using Cox regression models with breast cancer diagnosis as the outcome of interest, attained age as the underlying time variable, and adjustment for potentially confounding variables.

Results:
During follow-up (mean = 4.1 years), 1094 breast cancers (including ductal carcinoma in situ) occurred. An increased breast cancer risk was associated with earlier thelarche (age when breast growth begins; HR [95% CI] = 1.23 [1.02, 1.48], 1 [referent] and 0.80 [0.69, 0.93] for ≤10, 11–12 and ≥13 years respectively), menarche (initiation of menses; 1.06 [0.93, 1.21], 1 [referent] and 0.78 [0.62, 0.99] for ≤12, 13–14 and ≥15 years), regular periods (0.99 [0.83, 1.18], 1 [referent] and 0.74 [0.59, 0.92] for ≤12, 13–14 and ≥15 years) and age reached adult height (1.25 [1.03, 1.52], 1 [referent] and 1.07 [0.87, 1.32] for ≤14, 15–16 and ≥17 years), and with increased time between thelarche and menarche (0.87 [0.65, 1.15], 1 [referent], 1.14 [0.96, 1.34] and 1.27 [1.04, 1.55] for <0, 0, 1 and ≥2 years), and shorter time between menarche and regular periods (1 [referent], 0.87 [0.73, 1.04] and 0.66 [0.50, 0.88] for 0, 1 and ≥2 years). These associations were generally similar when considered separately for premenopausal and postmenopausal breast cancer.

Conclusions:
Breast duct development may be a time of heightened susceptibility to risk of carcinogenesis, and greater attention needs to be given to the relation of breast cancer risk to the different stages of puberty.

Item Type:	Journal Article
Subjects:	R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Divisions:	Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Clinical Trials Unit Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School
Library of Congress Subject Headings (LCSH):	Breast -- Cancer -- Research, Cancer -- Risk factors
Journal or Publication Title:	Breast Cancer Research
Publisher:	BioMed Central Ltd.
ISSN:	1465-542X
Official Date:	4 February 2014
Dates:	Date Event 4 February 2014 Published 30 January 2014 Accepted
Volume:	16
Number:	1
Number of Pages:	8
Page Range:	pp. 1-8
Article Number:	R18
DOI:	10.1186/bcr3613
Status:	Peer Reviewed
Publication Status:	Published
Access rights to Published version:	Open Access (Creative Commons)
Date of first compliant deposit:	15 March 2016
Date of first compliant Open Access:	15 March 2016
Funder:	Breakthrough Breast Cancer, Sir John Fisher Foundation, Great Britain. National Health Service (NHS), Institute of Cancer Research: Royal Cancer Hospital, National Institute for Health Research (Great Britain) (NIHR)

Request changes or add full text files to a record

Repository staff actions (login required)

View Item

Downloads